CClinicalTrials.gg
CompletedNCT04283682Updated Dec 8, 2022

Intervention Facilitates Oral Feeding in Premature Infants

An interventional study of Early skin-to-skin combined with breast-feeding in Premature, sponsored by Children's Hospital of Fudan University. Completed at 1 site in China. Open to participants aged Up to 72 Hours. Per ClinicalTrials.gov, last updated 2022-12-08.

Sponsored by Children's Hospital of Fudan University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
148
Allocation
Randomized
Ages
Up to 72 Hours
Sex
All
01

Study summary

Skin-to-skin combined with breastfeeding shortened the cycle of full-oral feeding in premature infants

Read the detailed description

This study is conducted at the level 3 NICU of the Children's Hospital of Fudan University, Shanghai, People's Republic of China, a tertiary medical center. Infants admitted to the NICU are all outborn infants.

The study is approved by the Ethics Committee of the Children's Hospital of Fudan University. Signed parental consent is obtained before participants'entry into the study. The RCT is conducted to evaluate the effectiveness of skin-to-skin combined with breastfeeding reduce the transition time from tube feeding to independent oral feeding.

The recruited infants are assigned to intervention group and control group.

Data are presented as means ± sds for continuous variables with normal distribution and percentages (%) for categorical variables. One-way analysis of variance and Fisher exact test is used to compare infants' baseline characteristics among the two groups. All statistical analyses are conducted using SPSS. A p value of less than 0.05 is regarded as statistically significant.

02

Conditions studied

  • Premature

Browse trials for

Keywords

  • Skin Contact
  • bresatfeeding
  • premature
  • oral feeding
03

In context

Premature Birth

2,553 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 148 is above the median of 84 across 1,688 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Children's Hospital of Fudan University is the lead sponsor of 262 studies on the registry; 92 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 72 Hours
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • gestational age ≤30 weeks
  • birth weight \< 1500g
  • age of admission \<72 hours
  • no congenital malformation

Exclusion criteria

Exclusion Criteria:

  • OI > 40
  • mother has trouble in communicating
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
148 participants (actual)

Study arms

  • No intervention
    standard group

    Feeding procedures follow clinical nursing practices

  • Experimental
    intervention group

    At appropriate time to invite mothers of premature infants into the NICU for skin-to-skin and breastfeeding

    Behavioral: Early skin-to-skin combined with breast-feeding

Interventions

  • BehavioralEarly skin-to-skin combined with breast-feeding

    Premature infants in the intervention group have access to skin-to-skin once a day for 1 hour at least once no ventilation support needed. During the skin-to-skin period,the breastfeeding is encouraged for about 5-10 minutes. The whole intervention stop until the baby achieve the full oral feeding.

06

What researchers measure

Primary outcomes

  1. Transition time from the initiation oral feeding to full oral feeding

    Transition time was defined as the days needed from introduction of oral feeding to obtain autonomous oral feeding when the nasogastric tube was removed and all the daily milk volume was taken from the bottle.

    Time frame: During the procedure

Secondary outcomes

  1. Exclusive breastfeeding at discharge

    Exclusive breastfeeding at discharge is defined as through breastfeeding without bottle feeding at discharge.On the day of discharge, newborns are weighed before regular feeding and then breastfed by their mothers. After breastfeeding, the baby is weighed again and the amount of breast milk obtained by sucking the mother's breast is assessed. If the two weight subtractions are greater than or equal to the amount required for once bottle feeding, the baby is considered exclusively breastfeding at discharge.

    Time frame: During the hospitalization, an average of 2 to 3 months

07

Study locations

1 site
  • Children's Hospital of Fudan University
    Shanghai, China
08

References and documents

Publications

  • Li L, Wang L, Niu C, Liu C, Lv T, Ji F, Yu L, Yan W, Dou YL, Wang Y, Cao Y, Huang G, Hu X. Early skin contact combined with mother's breastfeeding to shorten the process of premature infants </= 30 weeks of gestation to achieve full oral feeding: the study protocol of a randomized controlled trial. Trials. 2021 Sep 17;22(1):637. doi: 10.1186/s13063-021-05605-x. PubMed 34535164 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04283682
Lead sponsor
Children's Hospital of Fudan University
Responsible party
Sponsor
First posted
Feb 25, 2020
Start date
Apr 8, 2020
Primary completion
May 1, 2022
Completion
May 30, 2022
Last update
Dec 8, 2022

Study contacts

ling li Li
study chair · Wanyuan Road 399,Minhang District, Shanghai,China

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion